2023
DOI: 10.1002/ejoc.202300476
|View full text |Cite
|
Sign up to set email alerts
|

Stereocomplementary Synthesis of β‐Aryl Propanamines by Enzymatic Dynamic Kinetic Resolution‐Reductive Amination

Abstract: Chiral β-aryl propanamine is an important structure unit of bioactive molecules or drugs. But its efficient synthesis remains a challenging task. In this study, several enantiocomplementary imine reductases capable of dynamic kinetic resolution-reductive amination of sixteen 2-phenylpropanal derivatives of diverse structural characteristics with four different amines were identified through screening 196 imine reductases. Further-more, (S)-IR60, (R)-IR74 and (R)-IR207 were applied to access a series of differe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 46 publications
0
1
0
Order By: Relevance
“…In 2023, Zhu's group used IRED-catalyzed DKR of 2phenylpropionaldehyde derivatives to obtain a series of (R)and (S)-β-arylpropylamines with excellent conversion and enantioselectivity (90% to 99% ee). 93 This strategy provides an effective method for constructing such drug-active compounds. For example, this type of IRED catalyzes the highly stereoselective construction of 3-methylindoline, 94 a key intermediate for the treatment of phosphatase and spondylin homologo-deficient cancers; or another key intermediate of Akt/PBK phosphorylation inhibitors, a phase II clinical trial drug for the treatment of phosphatase and spondylin homologo-deficient cancers (Scheme 25a).…”
Section: Synthesis Of Importantmentioning
confidence: 99%
See 1 more Smart Citation
“…In 2023, Zhu's group used IRED-catalyzed DKR of 2phenylpropionaldehyde derivatives to obtain a series of (R)and (S)-β-arylpropylamines with excellent conversion and enantioselectivity (90% to 99% ee). 93 This strategy provides an effective method for constructing such drug-active compounds. For example, this type of IRED catalyzes the highly stereoselective construction of 3-methylindoline, 94 a key intermediate for the treatment of phosphatase and spondylin homologo-deficient cancers; or another key intermediate of Akt/PBK phosphorylation inhibitors, a phase II clinical trial drug for the treatment of phosphatase and spondylin homologo-deficient cancers (Scheme 25a).…”
Section: Synthesis Of Importantmentioning
confidence: 99%
“…In 2023, Zhu’s group used IRED-catalyzed DKR of 2-phenylpropionaldehyde derivatives to obtain a series of ( R )- and ( S )-β-arylpropylamines with excellent conversion and enantioselectivity (90% to 99% ee) . This strategy provides an effective method for constructing such drug-active compounds.…”
Section: Imine-reductase-mediated Synthesis Of Important Chiral Amine...mentioning
confidence: 99%
“…Imine reductases (IREDs) have been applied to catalyze reduction of various imines such as pyrrolines, piperidines, azepines, sulfur-containing cyclic imines, 3 H -indoles, tetrahydro-β-carbolines, and dihydroisoquinolines. IREDs and reductive aminases also catalyze asymmetric reductive amination of carbonyl compounds to form the corresponding chiral α- or β-amines. One-pot biocatalytic cascade of ene reductases and IREDs and a multifunctional biocatalyst EneIRED have been applied for the synthesis of chiral amines from α,β-unsaturated ketones, aldehydes, or imines; however, IREDs can only catalyze the reduction of imines or reductive amination of ketones and aldehydes instead of α,β-unsaturated compounds in most cases. In 2019, we identified a group of highly hindrance-tolerant IREDs that could efficiently convert 1-benzyl-HHIQs derivatives into the corresponding 1-benzyl-OHIQs including ( S )- 2a in 98% ee values . However, the low specific activity (0.035 U/mg) and low substrate concentration (10 mM) limit its practical application.…”
mentioning
confidence: 99%